Brief: Medicenna Reports Q1 Fiscal 2023 Financial Results
15/08/2022 12:15
Aug 15 (Reuters) - Medicenna Therapeutics Corp MDNA.TO :
* MEDICENNA REPORTS FIRST QUARTER FISCAL 2023 FINANCIAL
RESULTS
AND OPERATIONAL HIGHLIGHTS
* MEDICENNA THERAPEUTICS CORP - QTRLY LOSS PER SHARE $0.07
Source text for Eikon: ID:nGNX86fBGW
Further company coverage: MDNA.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Medicenna Therapeutics
See all newsBrief: Medicenna Therapeutics - Announces Two New U.S. Patents And One Allowed U.S. Patent Application
Brief: Medicenna Announces The Finalization Of The Terms Of Its Public Offering Of Securities
Brief: Medicenna Announces The Launch Of A Marketed Public Offering Of Securities
Brief: Medicenna Therapeutics Appoints Dr. Nageatte Ibrahim As Chief Medical Officer
Brief: Medicenna Therapeutics Reports Third Quarter Fiscal 2026 Financial Results